Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ortec Targeting Late 1999 Launch Of Cultured Skin Product Under HDE

This article was originally published in The Gray Sheet

Executive Summary

Ortec International is hoping to release its Composite Cultured Skin for the management of chronic ulcers in patients with junctional and dystrophic forms of epidermolysis bullosa in late 1999 following a recent humanitarian use designation from FDA.

You may also be interested in...

Bilayered Collagen Matrix Would Treat Venous Leg Ulcer, Autograft Wounds

Ortec will launch its OrCel wound care product for three FDA-cleared indications once the cryopreserved tissue gains marketing approval in the late spring for venous leg ulcer treatment, the firm says

COVID-19 Lockdown: India Pharma Manufacturing Limps Along Amid Challenges

Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts